NotalVision

Pharmaceutical & medical device company payment data from CMS Open Payments.

Total Payments
$379,274
Doctors Paid
967
Transactions
1,960
2019 Total
$71,614

Payment Breakdown by Category

Consulting$263,075 (69.4%)
Food & Beverage$48,139 (12.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $263,075 95 69.4%
Food and Beverage $48,139 758 12.7%
Honoraria $35,352 688 9.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,492 413 8.6%
Gift $195.37 5 0.1%
Education $21.07 1 0.0%

Payments by Medical Specialty

Specialty Total Paid Doctors Avg/Doctor
Ophthalmology $193,210 490 $394.31
Retina Specialist $124,647 72 $1,731
Optometrist $41,463 313 $132.47
Specialist $12,541 24 $522.53
Corneal and Contact Management $1,552 10 $155.18
Internal Medicine $955.34 12 $79.61
Cornea and External Diseases Specialist $909.85 1 $909.85
Surgery $816.82 4 $204.21
Student in an Organized Health Care Education/Training Program $815.73 9 $90.64
Physical Medicine & Rehabilitation $129.15 1 $129.15
Radiation Oncology $114.39 1 $114.39
Vision Therapy $111.82 3 $37.27
Geriatric Medicine $94.69 1 $94.69
Glaucoma Specialist $84.13 4 $21.03
General Practice $29.87 1 $29.87
Neuro-ophthalmology $10.76 1 $10.76
Vascular Neurology $8.51 1 $8.51
Ophthalmic Plastic and Reconstructive Surgery $7.78 1 $7.78

Top Paid Doctors — Page 39

No doctor payment records found.

About NotalVision

NotalVision has made $379,274 in payments to 967 healthcare providers, recorded across 1,960 transactions in the CMS Open Payments database. In 2019, the company paid $71,614. The top product by payment volume is ForeseeHome ($379,113).

Payments were distributed across 18 medical specialties. The top specialty by payment amount is Ophthalmology ($193,210 to 490 doctors).

Payment categories include: Food & Beverage ($48,139), Consulting ($263,075).

NotalVision is associated with 1 products in the CMS Open Payments database.